Keith Huff

Keith Huff currently serves as the Senior Director of Clinical & Value Evidence in Medical Affairs at Menarini Stemline, focusing on hematology and solid tumor oncology since April 2023. Prior to this role, Keith held various leadership positions in Medical Affairs and Health Outcomes at CSL, Bristol Myers Squibb, and Novartis, overseeing real-world evidence and health outcomes strategies related to chronic kidney disease and oncology. Additionally, Keith has experience in academia as an adjunct faculty instructor at Butler University Pharmacy School, and held significant roles in state healthcare and pharmaceutical research at Indiana State Medicaid, Sanofi, ELI Lilly and Company, and Dow AgroSciences. With a strong background in health outcomes, pharmacology, and medical account management, Keith Huff has established a comprehensive career in advancing medical affairs and health strategies across multiple therapeutic areas.